Therefore, in this review, we aim to discover the role of IL-1β in NSCLC, its involvement in inflammatory pathways, and its crosstalk with the PD-1/PD-L1 pathway as well as explore its potential role in the treatment of NSCLC. The gene discussed is CD274; the disease is non-small cell lung carcinoma.